Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Attendance
Registration fees
Hotel
Venue
Helpful info
Travel info
Programme
Abstract Submission
Postgraduate Teaching
Nurse Programme
Hands-on
Information for Presenters
In-person Networking
myUEG Community Area
Learn from Leaders
Mentoring
The UEG Night
Let's Meet
Women in GI Networking
Industry Programme
Industry Exhibition
Industry Symposia
Meet the experts sessions
Innovation Hub
List of Supporters & Exhibitors
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Author
Ulrike von Arnim
Diagnosis of EoE and how to measure response
Ulrike von Arnim
Pathophysiology and Diagnosis of EoE
Ulrike von Arnim
Diagnostic challenges: Endoscopy and histology
Ulrike von Arnim
From histopathology to non-invasive biomarkers: How to optimise diagnosis and monitoring
Ulrike von Arnim
A Deeper Dive Into the Clinical Implications of Type 2 Inflammation in EoE and Approaches to Patient Care (Sanofi)
Ulrike von Arnim
et al.
Achieving Control in EoE: Symptoms PLUS Histologic and Endoscopic Outcomes With Dupilumab (Sanofi Regeneron) (Complete Session)
Ulrike von Arnim
et al.
Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults
Ulrike von Arnim
et al.
RISK FACTORS FOR INTESTINAL AND EXTRA-INTESTINAL CANCERS IN INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE MONOCENTRIC COHORT STUDY
Ulrike von Arnim
et al.
EOSINOPHILIC OESOPHAGITIS - CLINICAL, ENDOSCOPIC AND HISTOLOGICAL SCORING SYSTEMS IN INITIAL DIAGNOSIS AFTER REMISSION INDUCTION AND IN REMISSION MAINTENANCE UNDER TOPICAL CORTICOSTEROIDS
Ulrike von Arnim
et al.
CORRELATION OF CALPROTECTIN AND BOWEL ULTRASOUND IN INFLAMMATORY BOWEL DISEASE (IBD)
Ulrike von Arnim
et al.
BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL
Ulrike von Arnim
et al.
Item 1 - 11 / 11
1
Chat with us
, powered by
LiveChat